For life sciences organizations developing treatments for European patients, insights from longitudinal European real-world data can help support go-to-market strategies. IBM MarketScan Treatment Pathways with European data access can help support your research and commercialization goals. For more information on how IBM MarketScan Treatment Pathways can help transform how you conduct life sciences research, please contact us at [email protected] or visit https://www.ibm.com/products/marketscan-treatment-pathways